Inactive Instrument

All News Dynavax Technologies Corporation Nasdaq

Equities

US2681581029

End-of-day quote Nasdaq Other stock markets
- ^USD	-

14/05	Dynavax Technologies Notified by US FDA That Application for Four-Dose Course of Hepatitis B Vaccine Lacks Sufficient Data	MT
14/05	Dynavax Application for Hepatitis B Treatment Ruled Insufficient by FDA	DJ

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dynavax Technologies Notified by US FDA That Application for Four-Dose Course of Hepatitis B Vaccine Lacks Sufficient Data	14/05	MT
Dynavax Application for Hepatitis B Treatment Ruled Insufficient by FDA	14/05	DJ
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine	14/05	RE
Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.	14/05	PR
Dynavax Technologies Corporation Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S	14/05	CI
Transcript : Dynavax Technologies Corporation, Q1 2024 Earnings Call, May 08, 2024	09/05
Dynavax Technologies: Q1 Earnings Snapshot	09/05	AQ
Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Posts Q1 Revenue $50.8M, vs. Street Est of $55M	09/05	MT
Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates	09/05	PR
Dynavax Technologies Corporation Reaffirms Financial Guidance for the Full Year 2024	09/05	CI
Dynavax Technologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
Dynavax Technologies : Additional proxy soliciting material – supplement	30/04	PU
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	25/04	PR
Dynavax Technologies Corporation Announces Chief Financial Officer Changes	02/04	CI
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference	28/02	PR
Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue	23/02	MT
Transcript : Dynavax Technologies Corporation, Q4 2023 Earnings Call, Feb 22, 2024	23/02
Dynavax Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	23/02	CI
Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Reports Q4 Revenue $55.6M, vs. Street Est of $52.7M	23/02	MT
Dynavax Technologies Corporation Provides Revenue Guidance for the Year 2024	23/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Dynavax Technologies Corporation Nasdaq

Equities

US2681581029

All News

Filters